Zobrazeno 1 - 10 of 514 pro vyhledávání: '"J. Burisch"'
1
Akademický článek
Is microbiota characterization a useful tool in clinical practice? An exploratory analysis of patients from the IBS – constant-care e-health monitoring initiative
Autor: M. Qais Al-sheikh, D. Vedel Ankersen, M. Bennedsen, C. Casén, K. Gravdal, G. Kirubakaran, J. Burisch, P. Munkholm
Publikováno v: Microbiota in Health and Disease, Vol 5 (2023)
Objective: Intestinal microbiota are prominent in the etiology of irritable bowel syndrome (IBS). In this exploratory study, we investigated short- and long-term changes in the microbiota of IBS patients after intervening with a low-FODMAP diet (LFD)
Externí odkaz: https://doaj.org/article/21cc09bef76a47558fc0cfcf38528858
Zobrazit plný text záznamu
2
P608 Time to onset of effect of biologics and small molecules in moderate-to-severe or acute severe ulcerative colitis – a systematic review and network meta-analysis
Autor: M Attauabi, E K Dahl, J Burisch, J Gubatan, O H Nielsen, J B Seidelin
Publikováno v: Journal of Crohn's and Colitis. 17:i735-i738
Background Time to response of advanced therapies is an important parameter due to the symptom load and risk of disease complications in moderate-to-severe ulcerative colitis (UC), but comparative data are lacking. We aimed to assess the comparative
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b70a39276904701199bea2db71cfbf9a
https://doi.org/10.1093/ecco-jcc/jjac190.0738
Zobrazit plný text záznamu
3
P555 Systematic review with meta-analysis: The impact of cancer treatments on the disease activity of inflammatory bowel diseases
Autor: S Grimsdottir, M Attauabi, E K Dahl, J Burisch, J B Seidelin
Publikováno v: Journal of Crohn's and Colitis. 17:i683-i686
Background The association between cancer treatments and exacerbation of IBD is unclear. We aimed to evaluate the effects of cancer treatments on the disease activity of IBD. Methods We performed a systematic review of the literature on cancer therap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce78fcdd2748bc6c0188a3d22c16f9e3
https://doi.org/10.1093/ecco-jcc/jjac190.0685
Zobrazit plný text záznamu
4
P293 Correlation between clinical measures to capture disease burden and prediction of the initial course of Crohn’s disease - findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)
Autor: M Attauabi, G R Madsen, F Bendtsen, J T Bjerrum, R Wilkens, K Theede, J F K F Ilvemark, T Boysen, J B Seidelin, J Burisch
Publikováno v: Journal of Crohn's and Colitis. 17:i437-i440
Background The initial disease burden of Crohn’s disease (CD) is dissimilar across patients; however, the ability to capture and predict the disease burden at diagnosis is scarcely investigated. The aim of the current study was to describe the init
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1877acf7d0f265e8c4b549cca8f9f1b8
https://doi.org/10.1093/ecco-jcc/jjac190.0423
Zobrazit plný text záznamu
5
P624 Investigating the symptom burden among European patients with moderate-to-severe Crohn’s disease using a real-world survey
Autor: J Burisch, A Hart, A Sturm, H Knight, C Rudolph, R Meadows, A Oortwijn, S Weatherby, R Rolph, F Dawod, A Armuzzi
Publikováno v: Journal of Crohn's and Colitis. 17:i753-i755
Background Despite treatment, patients with Crohn’s disease (CD) experience symptoms that affect their health-related quality of life (HRQoL). Understanding how CD affects HRQoL reveals valuable insight into disease impact. We aimed to examine the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7522d5a034f27bda7a0d15f199ed4bc
https://doi.org/10.1093/ecco-jcc/jjac190.0754
Zobrazit plný text záznamu
6
DOP54 Time to effect of biologics and small molecules for patients with moderately to severely active luminal Crohn’s disease – a systematic review and network meta-analysis
Autor: M Attauabi, C Steenholdt, J Burisch, J Gubatan, O H Nielsen, J B Seidelin
Publikováno v: Journal of Crohn's and Colitis. 17:i124-i126
Background Patients with moderately to severely active luminal Crohn’s disease (CD) have a high inflammatory burden, which can result in irreversible complications and therefore require urgent treatment. However, the speed of onset of efficacy of a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d277a1fa84b6aa7bf688dcda11c8494f
https://doi.org/10.1093/ecco-jcc/jjac190.0094
Zobrazit plný text záznamu
7
P226 Dietary patterns differ in the newly diagnosed IBD cohort with ethnicity as a key confounding variable, a case control study
Autor: L Dyall, J Kyle, R Misra, H Clark, J Limdi, R Cooney, M Brookes, E Fogden, S Pattni, N Sharma, T Iqbal, P Munkholm, J Burisch, N Arebi
Publikováno v: Journal of Crohn's and Colitis. 17:i379-i381
Background Inflammatory Bowel Disease (IBD) is driven by the interaction of the genome, environment, and diet. Our understanding of dietary risk factors is limited with a paucity of literature on specific dietary triggers for IBD. Furthermore, the ro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ad064f6357fd36cc57d72ac74db33359
https://doi.org/10.1093/ecco-jcc/jjac190.0356
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje